Advanced Biomed Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADVB research report →
Price Chart
About the company
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment.
- CEO
- Xiaomin Chen
- IPO
- 2025
- Employees
- 31
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on ADVB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.82M
- P/E
- -29.95
- PEG
- 0.04
- P/S
- 0.00
- P/B
- 0.89
- EV/EBITDA
- -6.89
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -20.71%
- ROIC
- -11.04%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-10,711+0.0%
- Op Income
- $-94,112
- Net Income
- $-101,524+96.4%
- EPS
- $-0.09-16.1%
- OCF Growth
- +91.5%
- FCF Growth
- +91.7%
- 52W High
- $24.23
- 52W Low
- $3.61
- 50D MA
- $8.23
- 200D MA
- $6.18
- Beta
- -0.36
- RSI (14)
- 40
- Avg Volume
- 1.77M
No earnings-call transcripts are available for ADVB yet.
- Free Float
- 40.6%
- Shares Outstanding
- 1.65M
- Float Shares
- 561.31K
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 27, 26 | Pau Hung To | other | 100,000 |
| Jul 27, 26 | Pau Hung To | other | 76,225 |
| Mar 3, 09 | CAPPS JOHN R | sell | 3,333,333 |
| Nov 14, 08 | CAPPS JOHN R | other | 2,000,000 |
| Nov 14, 08 | CAPPS JOHN R | sell | 2,000,000 |
| Nov 21, 07 | CAPPS JOHN R | other | 2,000,000 |
| Nov 6, 06 | CAPPS JOHN R | other | 0 |
| Jan 3, 05 | CAPPELLO ALEXANDER L | other | 25,000 |
| Mar 31, 04 | CAPPELLO ALEXANDER L | other | 0 |
| Mar 31, 04 | CAPPELLO ALEXANDER L | other | 155,945 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ADVB coverage
Recent articles, reports, and earnings notes.
No research on ADVB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADVB report →Advanced Biomed Inc. (NASDAQ:ADVB) Shares Shorted: Short Interest Down 39.8% in September
defenseworld.net · Oct 1
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
globenewswire.com · Feb 18
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
globenewswire.com · Feb 13
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
globenewswire.com · Dec 30
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
globenewswire.com · Sep 19
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
globenewswire.com · Mar 7
IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan
seekingalpha.com · Jul 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.